Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215921 | 1.00 | CES2 (0.58) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL217427 | 1.00 | CES2 (0.58) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL26180 | 1.00 | — | — | |
| SCHEMBL218386 | 1.00 | CES2 (0.58) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL8517604 | 1.00 | CES2 (0.58) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL216549 | 1.00 | CES2 (0.58) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL217137 | 0.97 | — | — | |
| Sulfur Dioxide SCHEMBL461977 | 0.92 | CES2 (0.50) | CES2CES1HDAC8HDAC6TSHR | |
| SCHEMBL216556 | 0.90 | — | — | |
| SCHEMBL5660 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452521-A1 | TETRAHYDROINDACENYL CATALYST COMPOSITION, CATALYST SYSTEM, AND PROCESSES FOR USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2017192226-A1 | TETRAHYDROINDACENYL CATALYST COMPOSITION, CATALYST SYSTEM, AND PROCESSES FOR USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-11-09 | — | — | WO | claimed |
| US-7041841-B1 | Process for producing crystalline poly-α-olefins with a monocyclopentadienyl transition metal catalyst system | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-05-09 | — | — | US | claimed |
| US-6262197-B1 | AS POLYMERIZATION CATALYST IN OLEFIN POLYMERIZATION | TARGOR GMBH (DE) | 2001-07-17 | — | — | US | claimed |
| US-5808122-A | Organometallic compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-15 | — | — | US | claimed |
| US-5726333-A | POLYMERIZATION CATALYSTS | HOECHST AG (DE) | 1998-03-10 | — | — | US | claimed |
| US-20240084056-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-03-14 | — | — | US | disclosed |
| WO-2023250240-A1 | LOW COST PROCESSES OF IN-SITU MAO SUPPORTATION AND THE DERIVED FINISHED POLYOLEFIN CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-4271718-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-11766669-B2 | Hexahydrocyclopenta[e]-as-indacen-1-yl and octahydrobenzo[e]-as-indacen-1-yl based catalyst complexes and process for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230242745-A1 | Process for Production of Thermoplastic Vulcanizates using Supported Catalyst Systems and Compositions Made Therefrom | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-08-03 | — | — | US | disclosed |
| US-20220213241-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2022-07-07 | — | — | US | disclosed |
| WO-2022146634-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| US-5585508-A | POLYMERIZATION CATALYST FOR POLYOLEFINS | HOECHST AG (DE) | 1996-12-17 | — | — | US | disclosed |
| EP-0742046-A2 | Organometallic compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-13 | — | — | EP | disclosed |
| EP-0742225-A1 | Organometallic compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-13 | — | — | EP | disclosed |
| EP-0739897-A1 | Polynuclear metallocene compound, process for preparing it and its use as catalyst | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-10-30 | — | — | EP | disclosed |
| EP-0694557-A2 | Organo metallic compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-01-31 | — | — | EP | disclosed |
| WO-1996000734-A1 | GROUP 4 METAL DIENE COMPLEXES AND ADDITION POLYMERIZATION CATALYSTS THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |
| EP-0654476-A1 | Metallocenes, their preparation and use as catalysts | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11766669-B2 | Hexahydrocyclopenta[e]-as-indacen-1-yl and octahydrobenzo[e]-as-indacen-1-yl based catalyst complexes and process for use thereof | MLX, ZYX, TXN | CES2 4035/4885CES1 3464/4885HDAC8 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.